Report
Staff Report: Limitless Surveillance at the FDA: Protecting the Rights of Federal Whistleblowers
Key Findings:
Insufficient authorization and guidelines. The monitoring was implemented with insufficient written authorization, no policy in place and no legal guidance given to the contractors conducting the monitoring. As a result, FDA captured communications that are protected by law, including communications with Congress, the media, and watchdog groups like Project on Government Oversight.
Unlawful capturing ...